Table 1. Patient characteristics.
Factors | n (%) |
---|---|
Sex | |
Female Male |
115 (32.0) 244 (68.0) |
Age | |
<65 years ≥65 years |
223 (62.1) 136 (37.9) |
Disease status | |
Locally advanced Metastatic Recurrence |
73 (20.3) 212 (59.1) 74 (20.6) |
History of prior chemotherapy | |
<No Yes |
265 (73.8) 94 (26.2) |
ECOG Performance status | |
0 1, 2 |
257 (71.6) 102 (28.4) |
UGT1A1 | |
Wild Single Double |
201 (56.0) 134 (37.3) 15 (4.2) |
CA19-9, U/mL median (range) | 1071.0 (0.4–368500) |
Albumin, g/dL median (range) | 3.9 (2.3–5.3) |
CRP, mg/dL median (range) | 0.3 (0.0–12.4) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; CA19-9, carbohydrate antigen 19-9; CRP, C-reactive protein.